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Prostaglandin Fti (PGFz,) selectively decreases the binding of ‘~51-labellcd epidermal growth factor ([‘z51]EGF) to intact Swiss 3T3 ceils. Scatchard 
analysis reveals that PGF:, decreases the number of high-affinity EGF bindingsiteswithnut changing the total number of receptors. Prostaglandins 
E, (PGE,). Ez (TGE,) or F, (PGF,) do not alter the EGF binding to these ceils and do not enhance the PCiFz, effect. R-59022 and R-59949, two 
diacylglyceroi k nase inhibitors. enhance the inhibitory effect of PGF>,. whereas down-modulation of protein kinase C (PKC) abolishes the eff’eft. 
These results indicate that PGF,, decreases EGF binding in Swiss 3T3 ceils via PKC activation. 
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1. INTRODUCTION 
Much evidence has shown that in confluent resting 
Swiss mouse 3T3 cells, mitogens such as bombesin, 
platelet derived growth factor or vasopressin cause in- 
creases in phosphatidylinositol metabolism, cellular 
diacylglycerol (DAG) content and protein kinase C 
(PKC) activity [l-6]. The stimulation of the latter mech- 
anism leads to the occurrence of a complex array of 
biochemical changes followed by the initiation of DNA 
replication and cell division [?I. 
Among these events it has been shown that in these 
cells either bombesin or vasopressin, as well as the PKC 
activators OAG or TPA, alter the [‘“SI]EGF binding 
proper;ies in these cells [S-l 11. This phenomenon is 
characterized by a decrease: in the number of high-affin- 
ity binding sites without changes in total apparent 
number of EGF receptors [Y-IO]. PKC down-modula- 
tion prevents the effect of these mitogens on [‘“51]EGF 
binding, indicating that PISC activation is involved in 
the alteration of this cellular membrane property 
[4,1 I, 123. Other results reveal that the addition of either 
insulin or insulin-like growth factor-I (IGF-I) produce 
a decreass in [‘Z51]EGF binding without PKC involve- 
ment [13]. 
Previous findings have shown that prostaglandin Fti 
(PGFti) stimulates changes in phosphoinositide metab- 
olism, PKC activation and cell growth in Swiss 3T3 cells 
[l&16]. In contrast, PC-E,, PGE2 or PGF, had little or 
no effect in stimulating these events [14,16]. Here we 
have shown that in these cells PGF4, selectively 
decreases the number of [‘Z51]EGF high-affinity re- 
ceptors. Only PGE? at high concentration (which has a 
little effect on phosphoinositide turnover and PKC 
activation) has a marginal effect on the [lZSI]EGF bind- 
ing to these cells. In addition, neither PGE, nor PGE2, 
which potentiate the PGF2= mitogenic effect, further 
decrease the PGF?, reduction of [‘ZSI]EGF binding. 
PKC down-modulation prevented the inhibitory effect 
of PGFZ,. These results indicate that the decrease in 
[“‘I]EGF binding triggered by PGF2, involves PKC 
activation. 
2. MATERIALS AND METHODS 
2.1. Cefl cuiruro, /‘2’I)EGF binding and ittiliation 01 DNA synthesis 
assuy conditiom 
Abbrcviurium: PGE,, prostaglandin E,; PGE,, prastaglandin Ez; 
PGF&,, prostaglandin Fa,; PGF,, prostaglandin F,; OAG. l-oleoyl- 
2-acetylglycerol; DAG, diacylgiycerul; TPA, 12.O-tetradecanoyl 
phorbol-13.acetate; R-59002. (6.[2-(4.[(4-fluorophenyi) phenyime- 
thylene]-l-pipcridinyi]-7-methyl)-5~-thi~~~lu[3,2-a]-pyrimidin-5-one; 
R-59949, (3-[2-[~[bis(~fluorophenyl)methyiene]-l-piperidinyi]ethyl] 
2,>-dihydro-2-thioxo+im-quinazoiinone). 
Swiss mouse 3T3 cells [ 171 r.vcrc propagated inDuibccco’s modified 
Eagle’s medium as previously described [14]. For [lsI]EGF binding 
and initiation of DNA synthesis, ceils were plated into 35.mm Petri 
dishes in conditions as described before [14]. OAG and prostaglandins 
were dissolved in ethanol such that the final ethanol concentration 
added to the culture medium was not greater thaII 0.55%. R-54022 and 
R-59949 were dissolved irs a 5 mM solution in ethanol and stored at 
-20°C, and then diluted in 0.065 M HCI before use. Initiation of DNA 
synthesis was measured IS reported previously [14]. 
Cc~r.~~ondertca arl(/~ss: L. Jimencz de Asua, INGEBI, Obiigado 
2490, 1428 Buenos Aires. Argentina. 
2.2. [“‘fjEGF bindhtg dercvnitzttion 
For [‘?‘I]EGF binding, the ceils were washed r&ice at 37°C with 
binding mdiurn and the 252~ was then per~ormccl asdescria by 
Corps and Brown [l3]. The [“‘I]EGF conrxntration and incubation 
time arc described for exh cxperimcnt. Total and non-specific 
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[lz’I]EGF binding (the latter carried out in the presexe of 200.fo!d 
excess unlabelled EGF) were 5% and 0.3%. respectively, .,f the total 
radioactivity. 
2 I 3. Chmiccds 
Purified EGF binding grade [IS! ;:‘~s !abelled with lzJl according to 
a described procedure [19]. Pros!aylandins, R-59022 and R-59949 
were the generous gift of Dr. I. Meringh, Upjohn Company, Ka- 
lamazoo and Dr, D. Chaffoy de Courcelles, Janssen Life Science 
Products, Beerse, Belgium, All remaining chemicals were purchased 
from SiL.rna. [merl~J+“H]Thymidine i I8 Wmmol) was purchased from 
New England Nuclear. 
3. RESUL<TS 
3.1. [‘2sJI]EGF bind& t#inity is reduced by PGF2, 
T!le addition of [1251]EGF to confluent resting Swiss 
3T3 cells results in a time-dependent increase in the 
amount of mitogen bound to the cells, reaching to a 
plateau after I h of exposure (Fig. 1A). In contrast, in 
the presence of PGF?, (300 @ml) the cell-associated 
[lz51]EGF was decreased by 46% at 1 11, although at later 
times PGF,, had less inhibitory effect (Fig. 1A). 
Scatchard analysis of [1?51]EGF binding revealed that 
PGF?, decreased the number of high-affinity receptors 
but did not alter the total number of receptors or the 
affmity of either class (& approximately 6 x 10-l’ M 
and 2 x !O-’ M, respectively; Fig. 1B). 
3.2. Sp~ificity of PGFt, as an inhibitor of [t’“I]EGF 
binding 
The action of PGF2% in decreasing the high-affinity 
[‘151]EGF binding sites is specific among other closely 
related prostaglandins. PGE,, PGE?, PGF2, or PGF,, 
added at l-1000 ng/ml, produced ifferent effects on the 
[‘“‘I]EGF bound to these cells (Fig. 2A). PGF2, induced 
a dose-dependent decrease in [“‘I]EGF binding, reach- 
ing to a plateau of 50% inhibition at 20 @ml (Fig. 2A). 
In contrast, PGE,, and PGF, had no effect, whilst 
Table I 
Differential effect of PGE, or PGE2 on PGF,-induced decrease in 
[“‘I]EGF binding aftinity and mitogenic response in Swiss 3T3 cells 
Additions % Inhibition of % Lahelled nuclei 
[‘?]EGF binding 
Control 0 0 
PGE, 0 0.7 
PCiE: 5.0 0.6 
PGE,+PGE, 10.0 0.8 
PGF2, 51.0 19.1 
PGF,,+PGE, 52.0 47.0 
PGFh+PGEI 53,o 49.0 
PGFz,+PGE,+PGE, 53.0 48.0 
Additions were as follows: PGE, (100 n;;/ml); PGE. (100 ndml); 
PGFz, (IO0 q/ml). [1Z51]EGF binding was determined for 60 min as 
it1 Fig. 2A. Initiation of DNA synthesis was measured after 28 II of 
stimulation as described in Section 2. The percentage oflabelled nuclei 
in the presence of EGF (I @ml) was 5% in agreement with previous 
results [25], 
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Fig. 1. (A) [lzSI]EGF binding time course minus (0) or plus (m) PGF*, 
(300 @ml). Cultures after being washed were incubated with I ml of 
binding medium containing 1 .O @ml [1z51]EGF (130,CVO cptn/ng) at 
37°C. Cell-associated radioactivity was determined as indicated in 
section 2. (5) Scatchard analysis of [tz51]EGF binding without (A) 01. 
witb (A) PGF, (300 ng/ml) at 37°C for GO min. [‘?]EGF was added 
from 0.1 to 40 ng/ml. Samples of tnediilm were removed at the end of 
incubation to determine the free [lzSI]EGF and specific binding as 
indicakd in s&ion 2. 
DGE, produced a similar effect to that of PGF2, only 
at concentrations 20- to 50-fold greater (Fig. 2A). Nei- 
ther PGE, nor PGE?, alone or together, enhance the 
[“‘I]EGF binding decrease induced by PGF&, but both 
PGE, and PGE, potentiate the PGF2, mitogenic 
response (Table I). 
3.3. PGF’?, reduction at [‘“I]EGF binding s#iniry re- 
quires PKC 
In common with the PKC activator TPA, the effect 
of PGF2, on \i251]EGF binding was temperature-de- 
pendent, being much reduced at 4’C (Fig. 2B). The 
requirement for PKC in the PGF,,-induced [“‘QEGF 
binding inhibition is shown in Fig. 3. l?GF2,, as well as 
bombesin and the PKC activators OAC or TPA, 
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Fig. 2. (A) Differential cffecu of varic-lus concentrations of PGE,, 
PGE,, PGF7, and PGF, on [‘?‘I]EGF binding at 37°C. Additions 
were as follows: (0) PGE,; (A) PGE:; (0) i?GF& and (*) PGF,. (B) 
Inhibition o~[‘~~~]EGF binding by increasing canccntrations ofPGF,, 
at 37°C (m) or 4°C (a). The inset shows the effect of TPA (30 ng/ml) 
at 37’C (open bar) and 4T (filled burr). Binding conditions wcrr: as 
in Fig. IA. Incubation time at 37°C was 60 min and at 4°C was 150 
min. 
produced a decrease in the percentage of [‘zsI]EGF as- 
sociated with the cells (Fig. 3). Cells pretreated with 
TPA to down-morlulate PKC exhibited a substantially 
Table II 
Effect of R-59022 and R-59949 on the PGF2, and Bombesin-induced 
decrease in [‘z”I]EGF binding affinity in Swiss 3T3 cells 
Additions % Inhibition of [‘*‘I]EGF bindine, 
Additions 
Control 
PGF, (3 @ml) 
ffiF2, (300 ntiml) 
Bombesin (17 @ml) 
+R-59022 +R-59949 
r, 1.4 5.0 
25 43.0 4&O 
47 66.0 65.0 
60 80.0 74.0 
R-59022 (8 pivt) nni R-59949 (O.ZpM) were added to the conditioned 
medium For 60 min before the assay. Cells were rapidly washed with 
binding medium without or with R-59922 or R-59949, and [‘ZsI]EGF 
binding was assayed as in Fig. 2A. 
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Fig. 3. ElTect of PKC down-modulation on the inhibition by insulin 
(100 @ml), bombcsie (17 n&ml), PGF, (3OC n&ml), OAG (100 
rdml) and TPA (30 n&ml) on [‘zSI]EGF binding at 37OC. For PKC 
down.modulation cells were treated with TPA (480 ndml) for 72 h 
prior to the experiment. [lz51]EGF binding was determined at 37°C for 
60 min. Conditions for determination were as in Fig. 1A. Standard 
error was less than 5% of the mean value. Open bars, without TPA; 
filled bars, with TPA. 
smaller decrease of [“‘I]EGF binding in response to 
PGF,, bombesin, OAG or TPA. In contrast, insulin 
decreases [“SI]EGF binding to the same extent regard- 
less of PKC down-modulation. In addition, R-59002 
and R-59499, two diacylylycerol kinase inhibitors 
[20,21] which raise cellular DAG content [22] and 
thereby potentiate PKC-mediated events In the Swiss 
3T3 cells [23] further enhance the effect of PGF2, (3 and 
300 r&ml) on [“51]EGF binding (Table II). Similar 
potentiation of the effect of bombesin also occurred 
(Table II). 
4. DISCUSSION 
Several findings show that in Swiss 3T3 cells the bind- 
ing affinity for [“‘I]EGF can be alter& by the activa- 
tion of different signaliing mechanisms [S-13]. Bom- 
besin and vasopressin, mitogens which increase phos- 
phatidylinositol breakdown and cellular DAG content, 
decrease the number of high-affinity EGF receptors via 
PKC activation without alterations in the total number 
of receptors or the affinity of either class [S, 161. In addi- 
tion, insulin or IGF-I, which in these cells do not stimu- 
late phosphatidylinositol metabolism or PKC activity, 
induce similar changes to [lz51]EGF binding affinity 
1131. Also, in PKC down-modulated cells platelet- 
derived groyjith factor induces a decrease in [“‘I]EGF 
binding by activating a different kinase [24]. 
Here we present evidence that in Swiss 3T3 cells 
PGF2, a mitogen which iriggers phosphatidylinositol 
metabolism, also decreases the number of high-affinity 
EGF receptors via PKC activation without changing 
the total number of receptors. The PGF2, effect is spe- 
cific since neither PGE, nor PGF,, which do not elicit 
237 
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changes in PIP:, or DAG content, fail to induce this 
alteration. Only PGE?, at high concentrations which 
increase phosphatidylinositol turnover, also decreased 
the EGF binding to these cells. In support for a possible 
diacylglycerol kinase involvement in modulating the 
[“‘l]EGF binding we have shown that two enzyme in- 
hibitors which increase cellular DAG [22] and PKC 
activity [23], potentiate this PGF&nduced event. In 
contrast PGE, or PGE2 can only potentiate the mito- 
genie effect of PGFz,, but do not enhance either the 
PKC- dependent phosphorylation of the 80 kDa protein 
[5,16] or the decrease in EGF receptor affinity. These 
results indicate that both PGE, and PGE:, potentiate the 
PGF?, mitogenic response, possibly by modulating an- 
other PKC-dependent event. Other findings reveal that 
PGF?, enhances the mitogenic action of EGF [25] 
suggesting that the PGF?, induced decrease of EGF 
receptor affinity might have implications in the regula- 
tion of the different signals triggered by both mitogens. 
Our future research is directed to unravel further dif- 
ferences in the events elicited by these growth factors. 
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